ADL
GMAB icon

Asset Dedication LLC’s Genmab GMAB Stock Holding History

Asset Dedication LLC’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193 Buy
+7
New +$186 ﹤0.01% 1208

Other funds holding GMAB

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

Asset Dedication LLC's GMAB Position: Q2 2026 in Review

Asset Dedication LLC opened a new position in Genmab (GMAB) in Q2 2026: 7 shares worth $193. The stake represents ﹤0.01% of the portfolio and ranks #1208 among its holdings.

81 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Asset Dedication LLC held 7 shares of Genmab worth $193 as of Q2 2026.
  • Genmab was a new Asset Dedication LLC position in Q2 2026.
  • Genmab made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #1208 holding.
  • 81 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.